Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02298504 · ClinicalTrials.gov registry record · Phase 4
Vital Pulp Treatment in Primary Teeth
A Phase 4 study of Indirect Pulp Cap and Pulpotomy, sponsored by University of Maryland, Baltimore.
- Active
- Registry status
- Phase 4
- Development phase
- 76
- Enrollment target
- 1
- Study location
NCT02298504 is a Phase 4 study of Indirect Pulp Cap and Pulpotomy that is active but no longer recruiting, run by University of Maryland, Baltimore. The registered enrollment target is 76 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02298504, a Phase 4 study of Indirect Pulp Cap and Pulpotomy, is active but no longer recruiting, sponsored by University of Maryland, Baltimore.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 4
- Development phase
- 76 participants
- Enrollment target
- 1
- Study location
Study Summary
In primary teeth, decay that is near the pulp (tooth nerve)is treated with either a pulpotomy or indirect pulp treatment if the tooth is not going to be extracted A pulpotomy involves removing the top 1/2 of the pulp, placing a medication/material on the pulp, covering the remaining pulp with a cement, and the restoring the tooth. The purpose of this pilot study is to gain preliminary information regarding the success of Biodentine, MTA, and IPT in the treatment of deep decay in children's primary molars.
Conditions Studied
Interventions
- DRUG Mineral Trioxide Aggregate
- DRUG Biodentin
- DEVICE Vitrebond
Study Locations (1)
Maryland
- University of Maryland School of Dentistry - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 76 participants |
| Start Date | 2018-07-01 |
| Est. Completion | 2026-12-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02298504
The ClinicalTrials.gov registry entry for NCT02298504 describes a study currently listed as active not recruiting, categorized as Phase 4. The registered enrollment target is 76 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Indirect Pulp Cap appearing as the primary indexed condition, and to 3 interventions - of which Mineral Trioxide Aggregate is the first listed.
NCT02298504 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT02298504 about?
NCT02298504 is a clinical study titled "Vital Pulp Treatment in Primary Teeth". In primary teeth, decay that is near the pulp (tooth nerve)is treated with either a pulpotomy or indirect pulp treatment if the tooth is not going to be extracted A pulpotomy involves removing the top 1/2 of the pulp, placing a medication/material on the pulp, covering the remaining pulp with a ceme...
What is the current status of trial NCT02298504?
This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 76 participants. The study started on 2018-07-01. Estimated completion is 2026-12-01.
What conditions does trial NCT02298504 study?
This clinical trial studies the following conditions: Indirect Pulp Cap, Pulpotomy, Vital Pulp Therapies.
What interventions are being tested in trial NCT02298504?
The interventions under investigation include: Mineral Trioxide Aggregate (DRUG), Biodentin (DRUG), Vitrebond (DEVICE).
Who is sponsoring clinical trial NCT02298504?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02298504 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Indirect Pulp Cap
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.